AVOSETTE Trademark

Trademark Overview


On Tuesday, December 13, 2022, a trademark application was filed for AVOSETTE with the United States Patent and Trademark Office. The USPTO has given the AVOSETTE trademark a serial number of 97715867. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 20, 2024. This trademark is owned by Medytox Inc.. The AVOSETTE trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; biological preparations for medical or veterinary purposes for the treatment and prevention of neurological disorders and muscle dystonia; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botul...
avosette

General Information


Serial Number97715867
Word MarkAVOSETTE
Filing DateTuesday, December 13, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; biological preparations for medical or veterinary purposes for the treatment and prevention of neurological disorders and muscle dystonia; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedytox Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do 28126
KR

Trademark Events


Event DateEvent Description
Friday, December 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 16, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2023SUSPENSION LETTER WRITTEN
Monday, May 8, 2023LETTER OF SUSPENSION E-MAILED
Monday, May 8, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 5, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, April 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 2, 2024SUSPENSION INQUIRY WRITTEN
Friday, February 2, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, February 2, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE